Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier BV in Urology
- Vol. 53 (3), 523-529
- https://doi.org/10.1016/s0090-4295(98)00542-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2–3 N0 M0 prostatic carcinomaUrology, 1997
- Effect of Neoadjuvant Endocrine Therapy (Combined Androgen Blockade) on Normal Prostate and Prostatic CarcinomaThe American Journal of Surgical Pathology, 1996
- Prognostic Significance of Positive Surgical Margins in Radical Prostatectomy SpecimensJournal of Urology, 1995
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995
- Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patientsCancer, 1995
- Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonistUrology, 1994
- Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1994
- Is Tumor Volume an Independent Predictor of Progression Following Radical Prostatectomy? A Multivariate Analysis of 185 Clinical Stage B Adenocarcinomas of the Prostate with 5 Years of FollowupJournal of Urology, 1993
- Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamideUrology, 1992
- Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1991